ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Bioxytran Inc (QB)

Bioxytran Inc (QB) (BIXT)

0.1399
0.00
(0.00%)
Closed March 10 3:00PM

Professional-Grade Tools, for Individual Investors.

BIXT News

Official News Only

BIXT Discussion

View Posts
govprs govprs 21 hours ago
Hold? Buy more?  What's Amanda price target can't read that chart from my phone
๐Ÿ‘๏ธ0
Zardiw Zardiw 22 hours ago
$BIXT - #DDAmanda Chart:



Z
๐Ÿ‘๏ธ0
Zardiw Zardiw 23 hours ago
Couple of nice days for $BIXT......#DDAmanda shows 200Day Highs on Price and $Traded..

Z
๐Ÿ‘๏ธ0
downdraft downdraft 2 days ago
I did see it. I'm here for the long haul. If I can quick flip-some other plays on the reversal of this market correction, I'll put half the profits in here.
๐Ÿ‘๏ธ0
Ecomike Ecomike 2 days ago
$BIXT $BIXT $BIXT
๐Ÿ‘๏ธ0
govprs govprs 2 days ago
Did you see insiders converted commons into preferreds. I can only surmise they are reducing the float for a reason

I'd love to see a buck or 2.  
๐Ÿ‘๏ธ0
downdraft downdraft 3 days ago
No new insider purchase filings yet. Hopefully a big deal is fast-approaching! Usually a trader group would sell out before the weekend.
๐Ÿ‘๏ธ0
govprs govprs 3 days ago
Maybe we get news next week 🤞
๐Ÿ‘๏ธ0
downdraft downdraft 3 days ago
Pretty impressive weekly move for no news. Maybe insiders are averaging down. Feels like longer term investors have jumped on board but there's still 35 minutes to go until the close.
๐Ÿ‘๏ธ0
govprs govprs 3 days ago
Check the news tab here on iHub.  There's an s-1 and I think notice.  All sec filings I believe

It was 18 million dollars I thought I read 18 million shares.  At yesterdays price of .08 I think that's less then 2 million dollars

We need a bigger breakthrough 


๐Ÿ‘๏ธ0
Biotech33NK Biotech33NK 3 days ago
TY! I'll check out Mike's Twitter account. What is the $18 million dollar offer? Where did you hear that from?
๐Ÿ‘๏ธ0
govprs govprs 3 days ago
Nothing I saw.  But on twitter Mike sheikh was promoting low market cap.  Not saying it's connected since his posts were not from today.  


There's a offering for 18 million coming.  Sometimes I've seen with biotech it pumps right before the offering.  Not saying this is why we got all the volume today. 

Fingers crossed something is actually going to happen 🤞
๐Ÿ‘๏ธ0
Biotech33NK Biotech33NK 3 days ago
Any update or news on what made the stock go up today? There are no PR out
๐Ÿ‘๏ธ0
govprs govprs 3 days ago
Good day here peeps 
๐Ÿ‘๏ธ0
Ecomike Ecomike 4 days ago
๐Ÿ‘๏ธ0
govprs govprs 4 days ago
What's the latest on heme foundation initiative 

Been like 6 months???

Also I see an S1.  I'm not saying these things to be negative but rather want to know why raise funds now? 18mil shares? Yikes 
๐Ÿ‘๏ธ0
Ecomike Ecomike 4 days ago
What we know already about $BIXT is huge:

BIXT is a Biotech. BIXT has a Patent covering 60+ virus applications for a non toxic carbohydrate based antivial, that cleared Covid19 in as little as 2 days, with no rebound. Cleared most of a Shingles skin outbreak as a cream.

The recent 10 Million dollars of zero dilution (not a loan, not a debt, no shares used) funding from the HEMEFoundation is for completing the work on the worlds first synthetic HEME Iron oxygen carrier.

https://hemefoundation.org/global-blood-shortage/

Seems to be convinced $BIXT has a massive future saving lives.

https://www.bioxytraninc.com/invest

https://www.bioxytraninc.com/press-releases/bioxytran-announces-preprint-of-shingles-case-study-showing-clearance-using-a-topical-galectin-3-antagonist

https://www.bioxytraninc.com/press-releases/bioxytran-launches-joint-venture-with-the-heme-foundation-for-development-of-universal-oxygen-carrier

https://assets-global.website-files.com/5cd9cf5f4183373f6b248799/63b59e37a80db77c70840b2a_Bioxytran%20Investor%207%20Jan%202022%20(NXPowerLite%20Copy).pdf


https://www.bioxytraninc.com/invest#press-releases

https://www.bioxytraninc.com/invest#presentation

https://www.otcmarkets.com/stock/BIXT/overview

https://www.bioxytraninc.com/resources#SCIENTIFIC-PUBLICATIONS

BIXT recorded presentation from 4 weeks ago.
๐Ÿ‘๏ธ0
Ecomike Ecomike 2 weeks ago
This is not the way to go people, Death, while permanent, is not a cure. BIXT Synthetic oxygen carrier will be the way to go. The BIXT VP mentions this in his $BIXT conference presentation he did this week, in the copy liked 3 posts below :

https://www.nbcnews.com/now/video/michigan-5-year-old-killed-in-hyperbaric-chamber-232448069521
👍️ 1
Ecomike Ecomike 2 weeks ago
The problems are get worse fast. $BIXT has the best solutions:

https://cdn.discordapp.com/attachments/1071577038294614066/1342915304317128824/image.png?ex=67bb5ed6&is=67ba0d56&hm=72655736087118e8cd903909eb9b9f970243e67f58eb56f3fa61064ea32b86ba&

Sadly $BIXT can not yet "Fix Stupid"
👍️ 1
Ecomike Ecomike 2 weeks ago
More bad news for Humans, good news for $BIXT

https://www.iheart.com/alternate/amp/2025-02-21-new-coronavirus-that-could-cause-another-pandemic-discovered-in-china/
๐Ÿ‘๏ธ0
Ecomike Ecomike 2 weeks ago
New Interview with more huge clues on $BIXT

Replay of latest Emerging Conference meeting.

๐Ÿ‘๏ธ0
govprs govprs 2 weeks ago
Interesting do sheiky doing a little investor push.  Anything on the heme oxygen foundation effort.  Been more than 6 months crickets since 
๐Ÿ‘๏ธ0
JoeBroke JoeBroke 2 weeks ago
Yeah. If you look at the volume, itโ€™s mostly like $5k here and $10k there. Nothing to impact the cap too much. As far as the latest growth conference, the main takeaways were: theyโ€™re frustrated with the current 8million market cap. Heh heh. So say we all. And theyโ€™re working lots of licensing pursuits. The dosing trials are still underway. I checked on that and learned a phase 1 dosing trial can take six months or more but a phase 2 or 3 trial often goes beyond a year. I hope theirs wraps up soon. But didnโ€™t sound like they expect it to. Alas.
๐Ÿ‘๏ธ0
govprs govprs 3 weeks ago
A lot of selling in the market I guess it's not bixt specific 
👍️ 1
govprs govprs 3 weeks ago
I guess the conference didn't go well pps  keeps dropping....
๐Ÿ‘๏ธ0
govprs govprs 3 weeks ago
Bixt presenting tomorrow 
https://goto.webcasts.com/starthere.jsp?ei=1696664&tp_key=a17d7ff4c2&sti=icontact


Hope Mikey Shiekah gets it right this time.  Focus on the science and shareholder value not some paid promotion crap.  
๐Ÿ‘๏ธ0
Monroe1 Monroe1 3 weeks ago
Heads are rolling. I am glad they spared the Indian Health Service and will be adding more money and manpower.
https://www.fiercehealthcare.com/regulatory/mass-layoffs-hhs-cdc-cuts-1300-probationary-workers-reports-say?oly_enc_id=4924G0643390I0A
๐Ÿ‘๏ธ0
RMacchio RMacchio 3 weeks ago
finally provide a more level chance for others to achieve success and at a quicker pace
The recent approvals of mRNA vaccines, Remdesivir, Paxlovid, and Lecanemab, despite little to no efficacy, are a stain on the NIH. Hopefully the day of Big Pharma dominance has come to an end and the NIH begins to focus on rigorous scientific evidence. Given the lightning speed of change under the new administration this transition could happen very quickly.
๐Ÿ‘๏ธ0
Monroe1 Monroe1 3 weeks ago
Yes, I caught that news release. The implications of JV could come from those pursuing the Bird flu is a real possibility. It's going to be interesting to see how this plays out with Nash/Mash. Now with the new administration the health agencies are undergoing some hefty review and change which is going to finally provide a more level chance for others to achieve success and at a quicker pace. Things are definitely looking up.
๐Ÿ‘๏ธ0
Ecomike Ecomike 3 weeks ago
The other galectin inhibitor drug stock, GALT released awesome news today on their Liver MASH trials, that will spill over into folks finally getting what $BIXT has, because $BIXT has a perfect trial already for N1H1 Covid, proof of their AI perfected antiviral, and is expanding into the Cancer treatment field to help triple the Merck Keytruda cancer cure from about 30% to about 100% effective, by pursuing a JV to show that their Galectin-3 Inhibitor can solve the Keytruda cancer-cure Galectin 3 problem, that is holding back the cure rate to Keytruda. Also they should be closing the door on Bird flu, etc, virus antiviral applications pretty soon.
👍️ 1
janga janga 3 weeks ago
Is BIXT just a Huff & Puff or is there true Visage in that Climatic Healing Zone?
๐Ÿ‘๏ธ0
Monroe1 Monroe1 4 weeks ago
Anecdotal evidence often is more accurate than trials where data and design (and/or CRO) can manipulate the outcomes and where the FDA can use secondary outcomes and sub unit data to give them the excuse to either approve or disapprove. It all depends on the relationship the company has with the corrupt FDA that first and foremost will protect the big pharma club members. If the data could impact the bottom line profits of competition big pharma or should any club members have competitive drugs in trials slated for future approval, then the company's drug trials will face all kinds of obstacles. Hopefully today RFK Jr gets his intended appointment!!

Thanks for relaying your experience.
👍️ 1 💯 1
Ecomike Ecomike 1 month ago
There is plenty of real science on the Galectin-3 connections, and value of Galectin-3 antivirals. Big Pharma, or WS Money just needs to WTF up and smell the massive value sitting here waiting.

Thanks for sharing your results. It means a whole lot to many of us.
👍️ 1
RMacchio RMacchio 1 month ago
I have another anecdotal experience on the effectiveness of Galectovid. Starting this past Saturday, I had a cold that was getting progressively worse in spite of the fact that I was megadosing vitamin C and Airborne. Yesterday I decided to try Galectovid - I took a one day supply (4 doses) and today my cold is gone.

I know that these two experiences are not a substitute for a controlled study but, given the science behind Galectovid and the successful Phase II COVID trial I believe this might be a cure for a broad range of viral infections.
👍️ 2
Ecomike Ecomike 1 month ago
I bought 3 of them and a friend bought 5 of them.
👍️ 1
Monroe1 Monroe1 1 month ago
Thanks for that info. I will buy some.
๐Ÿ‘๏ธ0
RMacchio RMacchio 1 month ago
I purchased a galectin inhibitor named Galectovic (classified as a medical food) from galectovid.com. It claims to "Combat Viral Infection by Cleansing Galectin-1 and Galectin-3". If you look in the science section of the website it shows the same plot that has been posted by BIXT covering the performance of Prolectin-M in their phase-II India trials. I'm guessing that BIXT is involved with the development of Galectovid which is why I bought it. I got this in case one of us contracted COVID or another viral infection - my wife and I are both over 70 and viral infections can be debilitating.

We had a good friend come down with a pretty bad case of COVID this week and we gave her one of the bottles we'd purchased which is a 5 day supply. By the second day on Galectovid she was feeling great and she quit taking it on the third day. Your're supposed to either chew (or dissolve in your mouth) the pills four times a day and our friend said the pills really taste good. When both I and my wife got COVID we were out of commission for almost 10 days. I think this is the real deal and I'm going to order more. And I'm going to encourage my friends to buy this product to have on hand.
👍️ 1
Monroe1 Monroe1 1 month ago
Moderna got a last minute payoff set in motion by biden/harris.

The officers passed up on taking their pay checks to conserve cash, and took shares at way higher prices in prior years.
Very bullish buy signal.
They converted the common shares to Preferred shares, also super bullish.
The OS tradable shares dropped 50%.


Such actions are rare these days. Can't get much more behind a stock than what they have done.
👍️ 1
Ecomike Ecomike 1 month ago
Depending on the events and timeline, and Licensing and JV terms, anywhere from $10 to $100/share, if licensing fees go to share buybacks, and reduce the OS share count, and if not bought out first by a SPAC , and if dividends start being paid....it can be a monster
👍️ 1
janga janga 2 months ago
Do you know the kind of numbers if this thing hits???
👍️ 1
govprs govprs 2 months ago
News out this morning 
👍️ 1
Ecomike Ecomike 2 months ago
This weekends reading assignments on $BIXT:
https://cdn.prod.website-files.com/5cd9cf5f4183373f6b248799/677c2fd911aeab616b586877_Bioxytran%20Cancer%20Metastasis%20Presentation.pdf

57 pages strong.
Eye Candy:


https://www.researchgate.net/publication/387742847_Immune_Checkpoint_Inhibitors_ICI_Prospects_for_Galectin-3_Modulation_to_Increase_Objective_Response_Rate_ORR_and_Remission-free_Survival_in_Oncology_Patients?channel=doi&linkId=677acf26e74ca64e1f4e65b9&showFulltext=true

https://www.researchgate.net/publication/387742847_Immune_Checkpoint_Inhibitors_ICI_Prospects_for_Galectin-3_Modulation_to_Increase_Objective_Response_Rate_ORR_and_Remission-free_Survival_in_Oncology_Patients?enrichId=rgreq-a16105199b988666faeca0ed02fa6e91-XXX&enrichSource=Y292ZXJQYWdlOzM4Nzc0Mjg0NztBUzoxMTQzMTI4MTMwMTQyMTIyMUAxNzM2MTAxNjY3MzEz&el=1_x_2&_esc=publicationCoverPdf
👍️ 1
govprs govprs 2 months ago
Sounds good $bixt 
๐Ÿ‘๏ธ0
Ecomike Ecomike 2 months ago
MM's have a new Dowe-Cheatem-Andhow game. They fill an ask slap at the ask except maybe 100 shares, and fill the last 100 or so at the bid, and lie to the market painting the tape with a red candle, and what looks like one trade. Been seeing a lot of that new BS since the Jan 2, new short disclosure rule went into effect
๐Ÿ‘๏ธ0
Ecomike Ecomike 2 months ago
The officers passed up on taking their pay checks to conserve cash, and took shares at way higher prices in prior years.
Very bullish buy signal.
They converted the common shares to Preferred shares, also super bullish.
The OS tradable shares dropped 50%.

All old news. None of which matters now.

Moderna just scored 570 Million dollars to develop another clot shot that will not work, and no will take, for Bird flue on Humans.
It was political. But Moderna is just another clot shot, fake Vaccine, no one will trust. Moderna product has side effects.

BIXT Galectin-3 is the worlds first, proven, non-toxic, oral pill, proven in successful phase II trials, BROAD Spectrum Antiviral in the world. Patented, and will work on Bird Flu, just like it does on other viruses.

Ever heard of BARDA? Hint....
No way $BIXT does not get noticed and fully funded now.
👍 2
govprs govprs 2 months ago
I bought shares today iHub marks it sold.   Funny things going on here
๐Ÿ‘๏ธ0
govprs govprs 2 months ago
Encouraging but also looks like it's convertible preferreds. You have any info on the terms? 
๐Ÿ‘๏ธ0
govprs govprs 2 months ago
I'm amazed everytime Mike Shiek presents at a conference this stock goes down 10% or more.  I don't mind I keep adding but can he get it right just once?
๐Ÿ‘๏ธ0
Monroe1 Monroe1 2 months ago
I guess he thinks the share price will increase. Nothing quite like insider buying. The company indications have a good chance of dominating. It will be interesting to see if they get some offers for buy out of if they only agree to collaborations or licensing. Bears watching closely. Bulls too.
👍️ 1
Ecomike Ecomike 2 months ago
Form 4 filed. Director ate nearly 100K shares at .315/share

💥 😎👀

https://ih.advfn.com/stock-market/USOTC/bioxytran-qb-BIXT/stock-news/95245634/form-4-statement-of-changes-in-beneficial-owners

👍️ 2 💥 1 😍 1 🤑 1 🤠 1

Your Recent History

Delayed Upgrade Clock